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Background: The World Health Organisation estimates that over 50% medicines are prescribed 
inappropriately and the main driver of antimicrobial resistance globally. There have only been a 
limited number of studies evaluating prescribing patterns in Namibia as the country strives to continue 
to provide comprehensive healthcare; majority using quantitative methods. Consequently, there is a 
need to address this. The objective is to evaluate prescribing practices among public health care 
facilities in Namibia to provide future guidance. Methods: A mixed methods medicines use evaluation 
was conducted to assess compliance to guidelines. Qualitative methods used to evaluate factors and 
practices associated with prescribing at three levels of health care, i.e. hospital, health centre and 
clinic. Main outcome measures for the quantitative study were compliance to current standard 
treatment guidelines (STGs),85% compliance to STGs is considered acceptable. Results: Of the 1,243 
prescriptions, 73% complied with the STGs and 69% had an antibiotic. Of the 3759 medicines (mean 
of 3.0±1.1 per prescription) prescribed, 64% had generic names. 94.6% of prescribers were aware and 
had access to STGs for reference purposes, with 82% reporting easy to use NSTG. Main thematic 
factors driving compliance to therapeutic guidance were programmatic, that is access to up-to date 
objective guidelines, continued education on their use, and ease of referencing using an index. Lack 
of systems to regulate noncompliance impacted on their use. Conclusion: Given concerns with 
adherence to guidelines, lack of INN prescribing and high use of antibiotics, a prescribing performance 
management system should be introduced in Namibia to improve prescribing. This will be monitored. 
